NCT04794387View on ClinicalTrials.gov

The Lymphoma and Leukemia Society Amended COVID-19 Registry

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

December 13, 2022

Study Completion Date

December 13, 2022

Conditions
Covid19
Interventions
BIOLOGICAL

Amended LLS COVID-19 Registry

Do people with blood cancer who did not develop antibodies after a complete COVID-19 vaccination, develop antoibodies after a COVID-19 booster?

Trial Locations (1)

10573

Lymphoma and Leukemia Society, Rye Brook

All Listed Sponsors
lead

Lymphoma and Leukemia Society

OTHER

NCT04794387 - The Lymphoma and Leukemia Society Amended COVID-19 Registry | Biotech Hunter | Biotech Hunter